The MIVI Group Strengthens Its Scientific Presence at the 2026 National Congress of the Spanish Pain Society

The MIVI Group Strengthens Its Scientific Presence at the 2026 National Congress of the Spanish Pain Society

The 2026 edition of the annual conference of the Spanish Pain Society (SED), held in Vitoria-Gasteiz from May 27 to 29, brought together some of Spain’s leading specialists in pain medicine, once again establishing itself as one of the most important scientific conferences in the field.

In this context, the MIVI Group has benefited from the active participation of seven professionals in various roundtables, presentations, and specialized courses, consolidating its position in key areas such as regenerative medicine, neurostimulation, radiofrequency, vertebrogenic pain, primary chronic pain, and treatment-resistant headaches.

A commitment aligned with innovation and an advanced approach to pain management

The presence of MIVI professionals at SED 2026 reflects an approach to pain management based on:

  • Diagnostic Accuracy
  • Indications for Advanced Techniques
  • Evidence-Based Clinical Innovation
  • Longitudinal follow-up of the patient
  • And a multidisciplinary approach aimed at restoring function and quality of life.

During the conference, specialists affiliated with Grupo MIVI participated in sessions focused on some of the most relevant and promising topics in modern pain medicine.

Regenerative Medicine and PRP for Pain Management

Dr. Guilherme Ferreira Dos Santos served as a speaker at the panel discussion titled “PRP Without Borders,” which focused on the use of platelet-rich plasma in tendons and tissue repair processes.

His presentation highlighted the importance of properly selecting patients, defining the anatomical target, and understanding regenerative medicine as part of a comprehensive plan for functional recovery.

In addition, he also discussed basivertebral nerve ablation for chronic vertebrogenic low back pain, an advanced technique that requires an accurate diagnosis and appropriate clinical indication.

Neurostimulation and Functional Recovery in Chronic Low Back Pain

Dr. Antonio Ojeda Niño served as moderator for one of the plenary sessions focused on restorative neurostimulation and activation of the multifidus muscle in patients with chronic low back pain.

The session addressed one of the most innovative approaches in functional neuromodulation: not limiting itself solely to pain management, but also focusing on stability, function, and motor control.

Radiofrequency and Advanced Treatment of Chronic Knee Pain

Dr. Jorge Orduña Valls spoke at a panel discussion on the interventional treatment of chronic knee pain using radiofrequency.

His participation highlighted key aspects such as:

  • Appropriate patient selection
  • Choosing High-Stakes Targets
  • Functionality and quality of life as therapeutic goals
  • And the role of radiofrequency therapy in patients with chronic knee pain.

Primary chronic pain: one of today’s major challenges

Dr. Víctor Mayoral Rojals moderated a panel discussion focused on the diagnostic and therapeutic challenges of primary chronic pain.

This is a particularly important topic given the clinical complexity of these patients and the need for integrated, individualized, and multidisciplinary approaches.

Implantable Neurostimulation and Advanced Therapies

Dr. Isaac Peña Vergara participated in a session on neurostimulation and implantable pain management, addressing the role of the implanting physician, clinical indications, the procedure, and post-implantation patient follow-up.

An initiative that highlights MIVI’s expertise in advanced therapies for patients with complex chronic pain.

Treatment-Resistant Headaches and the Responsible Clinical Use of Cannabinoids

Dr. Jesús de Santiago Moraga participated in a panel discussion on the role of medical cannabis in the management of treatment-resistant headaches.

The session addressed one of the topics currently generating the most interest in the field of pain medicine, focusing on:

  • The available scientific evidence
  • Safety
  • Patient Selection
  • And the need to maintain realistic clinical expectations.

Advanced Training in Radiofrequency

For her part, Dr. Gisela Roca served as an instructor in the pre-conference course on radiofrequency.

His presence reinforces Grupo MIVI’s commitment to advanced technical training and excellence in interventional procedures guided by anatomical precision and clinical safety.

MIVI and Its Commitment to Evidence-Based Pain Medicine

The participation of MIVI professionals in the SED 2026 Congress reflects the group’s commitment to pain medicine:

  • Based on scientific evidence
  • Focused on real functional results
  • Multidisciplinary
  • And focused on improving the patient’s quality of life.

Because continuing to make progress in pain medicine also means continuing to share knowledge, participating in scientific discourse, and staying at the forefront of the most innovative techniques and treatments.

Autor